196 related articles for article (PubMed ID: 20421337)
1. Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism.
Tordjman KM; Yaron M; Izkhakov E; Osher E; Shenkerman G; Marcus-Perlman Y; Stern N
Eur J Endocrinol; 2010 May; 162(5):925-33. PubMed ID: 20421337
[TBL] [Abstract][Full Text] [Related]
2. Patients with normocalcemic primary hyperparathyroidism may have similar metabolic profile as hypercalcemic patients.
Yener Ozturk F; Erol S; Canat MM; Karatas S; Kuzu I; Dogan Cakir S; Altuntas Y
Endocr J; 2016; 63(2):111-8. PubMed ID: 26581584
[TBL] [Abstract][Full Text] [Related]
3. Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism.
Beysel S; Caliskan M; Kizilgul M; Apaydin M; Kan S; Ozbek M; Cakal E
BMC Cardiovasc Disord; 2019 May; 19(1):106. PubMed ID: 31068134
[TBL] [Abstract][Full Text] [Related]
4. Normocalcemic Primary Hyperparathyroidism: A Comparison with the Hypercalcemic Form in a Tertiary Referral Population.
Pierreux J; Bravenboer B
Horm Metab Res; 2018 Nov; 50(11):797-802. PubMed ID: 30396209
[TBL] [Abstract][Full Text] [Related]
5. Normocalcemic hyperparathyroidism is associated with complications similar to those of hypercalcemic hyperparathyroidism.
Tuna MM; Çalışkan M; Ünal M; Demirci T; Doğan BA; Küçükler K; Özbek M; Berker D; Delibaşı T; Güler S
J Bone Miner Metab; 2016 May; 34(3):331-5. PubMed ID: 26056016
[TBL] [Abstract][Full Text] [Related]
6. Augmentation of central arterial pressure in mild primary hyperparathyroidism.
Smith JC; Page MD; John R; Wheeler MH; Cockcroft JR; Scanlon MF; Davies JS
J Clin Endocrinol Metab; 2000 Oct; 85(10):3515-9. PubMed ID: 11061493
[TBL] [Abstract][Full Text] [Related]
7. An overview of normocalcemic primary hyperparathyroidism.
Pawlowska M; Cusano NE
Curr Opin Endocrinol Diabetes Obes; 2015 Dec; 22(6):413-21. PubMed ID: 26512768
[TBL] [Abstract][Full Text] [Related]
8. Twenty-four hour Holter ECG in normocalcemic and hypercalcemic patients with hyperparathyroidism.
Pepe J; Magna A; Sonato C; Sgreccia A; Colangelo L; Occhiuto M; Cilli M; Minisola S; Cipriani C
J Endocrinol Invest; 2024 Jun; 47(6):1499-1504. PubMed ID: 38141155
[TBL] [Abstract][Full Text] [Related]
9. [Normocalcemic primary hyperparathyroidism].
Spivacow FR; Sapag Durán A; Zanchetta MB
Medicina (B Aires); 2014; 74(6):457-61. PubMed ID: 25555006
[TBL] [Abstract][Full Text] [Related]
10. Comparative utility of preoperative imaging in normocalcemic versus hypercalcemic primary hyperparathyroidism.
Montgomery KB; Gillis A; Ramonell KM; Fazendin JM; Lindeman B; Chen H
Am J Surg; 2023 Feb; 225(2):293-297. PubMed ID: 36175194
[TBL] [Abstract][Full Text] [Related]
11. Biochemical markers of endothelial activation in primary hyperparathyroidism.
Fallo F; Cella G; Casonato A; Ermani M; Vettor R; Zanella S; Lumachi F
Horm Metab Res; 2006 Feb; 38(2):125-9. PubMed ID: 16523414
[TBL] [Abstract][Full Text] [Related]
12. ECHOCARDIOGRAPHIC FINDINGS IN PATIENTS WITH NORMOCALCEMIC PRIMARY HYPERPARATHYROIDISM COMPARED WITH FINDINGS IN HYPERCALCEMIC PRIMARY HYPERPARATHYROID PATIENTS AND CONTROL SUBJECTS.
Pepe J; Colangelo L; Sonato C; Occhiuto M; Ferrara C; Del Fattore A; Santori R; Mastrantonio M; Sgreccia A; Minisola S; Cipriani C
Endocr Pract; 2021 Jan; 27(1):21-26. PubMed ID: 33475498
[TBL] [Abstract][Full Text] [Related]
13. Parathyroidectomy in asymptomatic primary hyperparathyroidism reduces carotid intima-media thickness and arterial stiffness.
Cansu GB; Yılmaz N; Özdem S; Balcı MK; Süleymanlar G; Arıcı C; Boz A; Sarı R; Altunbaş HA
Clin Endocrinol (Oxf); 2016 Jan; 84(1):39-47. PubMed ID: 26399562
[TBL] [Abstract][Full Text] [Related]
14. Arterial structure and function in mild primary hyperparathyroidism is not directly related to parathyroid hormone, calcium, or vitamin D.
Ring M; Farahnak P; Gustavsson T; Nilsson IL; Eriksson MJ; Caidahl K
PLoS One; 2012; 7(7):e39519. PubMed ID: 22815708
[TBL] [Abstract][Full Text] [Related]
15. [Primary hyperparathyroidism - new clinical forms of the disease].
Zajíčková K
Vnitr Lek; 2017; 63(9):604-608. PubMed ID: 29120658
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound evaluation of carotid artery in primary hyperparathyroidism.
Fallo F; Camporese G; Capitelli E; Andreozzi GM; Mantero F; Lumachi F
J Clin Endocrinol Metab; 2003 May; 88(5):2096-9. PubMed ID: 12727960
[TBL] [Abstract][Full Text] [Related]
17. Chronic constipation in hypercalcemic patients with primary hyperparathyroidism.
Ragno A; Pepe J; Badiali D; Minisola S; Romagnoli E; Severi C; D'Erasmo E
Eur Rev Med Pharmacol Sci; 2012 Jul; 16(7):884-9. PubMed ID: 22953636
[TBL] [Abstract][Full Text] [Related]
18. Changes in insulin sensitivity and glucose and bone metabolism over time in patients with asymptomatic primary hyperparathyroidism.
Ayturk S; Gursoy A; Bascil Tutuncu N; Ertugrul DT; Guvener Demirag N
J Clin Endocrinol Metab; 2006 Nov; 91(11):4260-3. PubMed ID: 16895964
[TBL] [Abstract][Full Text] [Related]
19. Normocalcemic, subclinical, asymptomatic primary hyperparathyroidism in patients with goiter or papillary thyroid cancer--preliminary report. Normocalcemic primary hyperparathyroidism and thyroid pathology.
Niedźwiecki S; Kuzdak K; Kaczka K; Pomorski L
Wiad Lek; 2007; 60(5-6):228-30. PubMed ID: 17966885
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular manifestations of primary hyperparathyroidism: a narrative review.
Pepe J; Cipriani C; Sonato C; Raimo O; Biamonte F; Minisola S
Eur J Endocrinol; 2017 Dec; 177(6):R297-R308. PubMed ID: 28864535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
